Full-Time

Senior Manager or Director

Corporate FP&A

Deadline 4/10/27
Mercalis

Mercalis

1,001-5,000 employees

Life sciences commercialization, analytics, and partnerships

No salary listed

Morrisville, NC, USA

In Person

Category
Finance & Banking (1)
Required Skills
NetSuite
Forecasting
Financial analysis
Anaplan
Excel/Numbers/Sheets
Financial Modeling

Get referred to Mercalis

See people who can refer or advise you

Requirements
  • The candidate must have at least 7 years of experience in FP&A, corporate finance, or accounting.
  • The candidate must have strong experience leading corporate financial reporting and forecasting processes, including developing and maintaining all three financial statements.
  • The candidate must have demonstrated experience preparing Board, executive, and investor-level financial presentations.
  • The candidate must have proven experience building and maintaining three-statement financial models and Free Cash Flow forecasts.
  • The candidate must have a strong understanding of working capital drivers and cash flow dynamics.
  • The candidate must have advanced Excel and financial modeling capabilities.
  • The candidate must be able to translate financial analysis into clear executive presentations and business insights.
Responsibilities
  • Lead the monthly financial reporting process across the company.
  • Produce the internal Financial Review Package summarizing company financial performance and highlighting margin expansion ideas.
  • Prepare and maintain Monthly Operating Review materials for executive leadership.
  • Develop and maintain Board reporting materials with clear and actionable financial insights.
  • Translate complex financial results into clear executive-level narratives and presentations.
  • Provide departmental financial reporting and analysis for corporate OPEX and COGS functions not covered by business unit finance leads.
  • Own headcount reporting, including tracking, forecasting, and reconciliation with operating plans.
  • Prepare financial reporting packages for lenders and financing partners and flag covenant noncompliance concerns.
  • Maintain a single source of truth for actual results.
  • Lead the monthly forecast consolidation process across business units and corporate functions.
  • Own development and maintenance of three-statement forecasting covering the Profit & Loss, Balance Sheet, and Cash Flow Statement.
  • Develop and maintain Free Cash Flow forecasting, including working capital drivers, capital expenditures, and cash conversion dynamics.
  • Own and maintain the company’s corporate financial model, ensuring accurate forecasting of operating performance, balance sheet impacts, and Free Cash Flow generation.
  • Partner with accounting to align operational forecasts and financial statement projections.
  • Coordinate the annual budgeting process, including timeline management, consolidation, and executive review materials.
  • Maintain a consolidated list of risks and opportunities from business unit leads and others, and proactively flag them before they occur.
  • Perform ad hoc reporting and analysis at the request of the Head of FP&A or Chief Financial Officer.
  • Lead the evaluation, implementation, and ongoing management of the company’s FP&A planning system.
  • Develop scalable planning and reporting frameworks that support company growth.
  • Drive consistency and standardization in reporting structures, forecasting methodologies, and financial definitions across business units.
  • Improve the efficiency and automation of financial reporting processes.
  • Deliver clear, decision-useful insights with a concise narrative outlining what occurred, the underlying reasons, and anticipated next steps for leadership.
  • Establish quality control processes to ensure reporting accuracy, timeliness, and reliability.
  • Partner with business unit FP&A leaders to ensure consistent and high-quality financial narratives.
  • Identify opportunities to improve forecasting accuracy and reporting efficiency.
  • Work initially as an individual contributor with the Head of FP&A and business unit finance leads.
  • Build and lead elements of the Corporate FP&A team as the organization grows.
  • Help establish scalable processes that support a growing FP&A organization.
Desired Qualifications
  • CPA designation.
  • Experience implementing or managing FP&A planning tools such as Anaplan, Adaptive, Planful, or Pigment.
  • Experience with NetSuite.
  • Experience in private-equity-backed or high-growth environments.
  • Pharmaceutical services or healthcare services industry experience.

Mercalis provides commercialization services for life sciences and pharmaceutical companies. It uses data analytics, industry expertise, and technology to maximize value across both product and patient journeys, guiding from value discovery to delivery. Its offerings include insights, strategy, data, and solutions that help life sciences leaders address critical business issues and support strategic decision-making. The company also connects patients with life sciences products and programs through data-driven access initiatives, and it conducts scalable outreach to healthcare providers to generate leads, educate, and engage across the provider value chain. By focusing on partnerships with life sciences companies, Mercalis aims to unlock product value and improve patient lives.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Morrisville, North Carolina

Founded

N/A

Get referred to Mercalis

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Valeris reported 739 employees in March 2026, signaling post-merger operating expansion.
  • The 2025 merger unites patient support with commercialization, strengthening cross-sell opportunities.
  • Active hiring in 2026 indicates demand for integrated commercialization and patient-access services.

What critics are saying

  • Integration failures after May 2025 could disrupt clients and trigger account losses in 2026.
  • LUXE HEALTH v. MERCALIS INC. shows contract dispute exposure in federal court.
  • Pharma and payer customers can unbundle services, compressing Valeris pricing by 2026.

What makes Mercalis unique

  • Mercalis built commercialization, market access, and provider engagement across one workflow.
  • May 2025 merger with PharmaCord created Valeris, a full patient-services platform.
  • Permira-backed scale plus Odyssey heritage gives Valeris broader enterprise reach.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Professional Development Budget

Training Programs

Company News

PR Newswire
Apr 3rd, 2025
Triangle Insights Group By Mercalis Announces Promotion Of Parker Guse

Premier life sciences consulting firm promotes Senior Principal to PartnerDURHAM, N.C., April 3, 2025 /PRNewswire/ -- Triangle Insights Group by Mercalis (Triangle), a premier strategy consulting firm that delivers high-impact solutions across the life sciences value chain, today announced a promotion that recognizes high achievement and further strengthens the firm's senior leadership team. Triangle, acquired by life sciences commercialization company Mercalis in April 2022, has named Parker Guse a Partner.Guse, who joined Triangle in June 2014, has over a decade of experience in the life sciences industry. In his role, Parker leads Triangle's business development and corporate strategy center of excellence. He has extensive experience in both buy-side and sell-side diligence that spans pharma, biotech, and private equity clients. His typical projects include due diligence, commercial assessment, and portfolio and commercialization strategy. Guse has been involved in over 300 projects spanning all therapeutic areas, with a focus on oncology, autoimmune disorders, and rare diseases.Guse holds a BA in Economics from the University of North Carolina at Chapel Hill."Parker has made invaluable contributions to Triangle's success throughout his years at the firm," said Megan Thomas, Triangle's General Manager

Business Wire
Mar 13th, 2025
PharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical Industry

PharmaCord LLC (“PharmaCord”), a leading provider of patient services for the biopharmaceutical industry, and Mercalis, an integrated life sciences co

Permira
Mar 12th, 2025
PharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical Industry

By combining PharmaCord's expertise in patient services with Mercalis's advanced technology infrastructure, experienced commercial team, and fully integrated market access offerings, the new entity is poised to be a leading provider of patient access solutions to the biopharmaceutical industry.